The local medical landscape is buzzing with the emergence of retatrutide, a innovative dual GIP and GLP-1 receptor agonist showing remarkable results in early trials for managing obesity. This medication https://setbookmarks.com/story21796496/retatrutide-australia-australia-a-potential-solution-for-weight-management